Volume 32, No 4, Apr 2022

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 32 Issue 4, April 2022: 331-332

RESEARCH HIGHLIGHTS

Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine

Hua Peng¹ , Yang-Xin Fu^2,*

¹Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
²Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, China
Correspondence: Yang-Xin Fu(yangxinfu@tsinghua.edu.cn)

New adjuvants that potently improve vaccine efficacy with extremely low toxicity are urgently needed. In a recent study in Cell Research, Liu et al. show that a new STING agonist CF501 facilitates a SARS-CoV-2 subunit vaccine to elicit robust neutralizing antibody response against several subtypes of sarbecovirus and protects experimental animals from SARS-CoV-2 infection.

https://doi.org/10.1038/s41422-022-00634-w

FULL TEXT | PDF

Browse 409